바이오프로세스 자동화 소프트웨어 시장 규모, 점유율 및 동향 분석 리포트 : 유형별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Bioprocess Automation Software Market Summary

The global bioprocess automation software market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 3.84 billion by 2033, growing at a CAGR of 13.84% from 2025 to 2033. The industry is driven by the rising adoption of digitalization and automation in biomanufacturing, enhancing efficiency and process consistency.

Additionally, growing demand for real-time monitoring and advanced data analytics supports quality control and regulatory compliance.

Rising Adoption Of Digitalization And Automation In Biomanufacturing Processes

The rising adoption of digitalization and automation in biomanufacturing processes is a major driver of the bioprocess automation software market, as pharmaceutical and biotechnology companies increasingly seek to enhance efficiency, reduce variability, and ensure regulatory compliance. Automation software enables seamless integration of upstream and downstream operations, real-time monitoring of critical parameters, and advanced process control through platforms like MES, SCADA, and PAT. By replacing manual, error-prone tasks with intelligent data-driven systems, manufacturers can achieve faster scale-up, improved batch consistency, and optimized resource utilization. This digital shift is also aligned with the industry's move toward continuous bioprocessing and Industry 4.0 principles, making automation software central to achieving smarter, more connected, and more agile production environments.

The need for bioprocess automation is anticipated to increase as the world's healthcare system depends more on biology for novel treatments, making it an essential part of contemporary pharmaceutical production. Automation in bioprocessing allows manufacturers to optimize production workflows, improve consistency, and increase throughput without compromising quality. Biopharmaceutical companies can produce larger biologics with reduced variability, faster turnaround times, and lower operational costs by integrating robotics, AI, and advanced monitoring systems.

Global Bioprocess Automation Software Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bioprocess automation software market report on the basis of type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Distributed Control Systems
• Supervisory Control and Data Acquisition
• Manufacturing Execution Systems
• Laboratory Information Management Systems
• Process Analytical Technology
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Upstream Processing
• Downstream Processing
• Quality Control
• Manufacturing Operations
• Data Management
• End use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & biotech manufacturers
• CDMOs & CMOs
• Academic & research institutions
• Contract testing & analytical labs
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Details
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Rising adoption of digitalization and automation in biomanufacturing processes
    • 3.3.1.2. Growing demand for real-time monitoring and data analytics in bioprocessing
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. High implementation and integration costs of automation software
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Type Business Analysis

• 4.1. Type Segment Dashboard
• 4.2. Global Bioprocess Automation Software Market Type, Movement Analysis
• 4.3. Global Bioprocess Automation Software Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Distributed Control Systems
  • 4.4.1. Global distributed control systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Supervisory Control and Data Acquisition
  • 4.5.1. Global supervisory control and data acquisition market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Manufacturing Execution Systems
  • 4.6.1. Global manufacturing execution systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Laboratory Information Management Systems
  • 4.7.1. Global laboratory information management systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.8. Process Analytical Technology
  • 4.8.1. Global process analytical technology market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Bioprocess Automation Software Market, Application, Movement Analysis
• 5.3. Global Bioprocess Automation Software Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Upstream Processing
  • 5.4.1. Global upstream processing market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Downstream Processing
  • 5.5.1. Global downstream processing market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Quality Control
  • 5.6.1. Global quality control market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Manufacturing Operations
  • 5.7.1. Global manufacturing operations market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.8. Data Management
  • 5.8.1. Global data management market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End use Business Analysis

• 6.1. End use Segment Dashboard
• 6.2. Global Bioprocess Automation Software Market End use, Movement Analysis
• 6.3. Global Bioprocess Automation Software Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
• 6.4. Pharmaceutical & biotech manufacturers
  • 6.4.1. Global pharmaceutical & biotech manufacturers market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. CDMOs & CMOs
  • 6.5.1. Global CDMOs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Academic & research institutions
  • 6.6.1. Global academic & research institutions market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Contract testing & analytical labs
  • 6.7.1. Global contract testing & analytical labs market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Bioprocess Automation Software Market: Regional Estimates and Trend Analysis, by Type, Application, & End-Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.5.5. Singapore
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Singapore Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Australia Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Thailand Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.5.8. South Korea
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. South Korea Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Bioprocess Automation Software Market, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Bioprocess Automation Software Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Rockwell Automation
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Amgen
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Merck KGaA
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Eppendorf SE
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Andrew Alliance (Waters)
    • 8.4.6.1. Overview
    • 8.4.6.2. Product Benchmarking
    • 8.4.6.3. Strategic Initiatives
  • 8.4.7. Agilitech
    • 8.4.7.1. Overview
    • 8.4.7.2. Product Benchmarking
    • 8.4.7.3. Strategic Initiatives
  • 8.4.8. Bioengineering AG
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Synthace
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives